The effects of serotonin on reproductive function were examined using hamster spermatozoa. When serotonin at concentrations from 1 fmol/l to 1 mmol/l was added to modified Tyrode's albumin lactate pyruvate (mTALP) medium, hyperactivation was significantly enhanced. Agonists and antagonists of 5-hydroxytryptamine hydrochloride (5-HT) receptors (5-HT 2 and 5-HT 4 receptors) were added to the medium. Both 5-HT 2 and 5-HT 4 receptor agonists significantly enhanced hyperactivation, although the effect was greater than the former. However, both 5-HT 2 and 5-HT 4 receptor antagonists significantly suppressed serotonin-enhanced hyperactivation, with the former suppressing stimulation by a lower concentration of serotonin than the latter. These results indicate that serotonin enhances hyperactivation via 5-HT 2 and/or 5-HT 4 receptors in a dose-dependent manner.
Introduction
The neurotransmitter serotonin (5-hydroxytryptamine hydrochloride or 5-HT) is formed in the body by the hydroxylation and decarboxylation of tryptophan. After release from serotonergic neurons, serotonin is recaptured by an active reuptake mechanism and inactivated by monoamine oxidase to form 5-hydroxyindoleacetic acid, the principal urinary metabolite of serotonin. In the pineal gland, serotonin is converted to N-acetyl-5-methoxytryptamine (melatonin). Serotonin has multiple actions in diverse tissues. In general, serotonin actions are mediated by 5-HT receptors, characterized, and cloned as 5-HT 1 , 5-HT 2 , 5-HT 3 , 5-HT 4 , 5-HT 5 , 5-HT 6 , and 5-HT 7 receptors. Most 5-HT receptors are G-protein-coupled receptors and act on adenylyl cyclase (AC) or phospholipase C (PLC). 5-HT 3 receptors, however, are ion channel-coupled receptors (Noda et al. 2004 , Ganong 2005 .
Because serotonin and 5-HT receptors are found in oocytes, cumulus-oocyte complexes (COC), follicular fluid, and embryos in mammals (Dubé & Amireault 2007) , some consider that serotonergic signals are associated with regulation of steroidogenesis, oocyte maturation, and embryonic development. Another study (Meizel & Turner 1983) demonstrated that serotonin and 5-methoxytryptamine, a 5-HT 4 receptor agonist, induce an acrosome reaction (AR) in hamster spermatozoa. They also demonstrated that serotonin-induced and serotonin agonist-induced ARs were inhibited by 4-(5H-dibenzo [a,d] cyclohepten-5-ylidene)-1-methyl-,hydrochloride,hydrate (2:3) (cyproheptadine hydrochloride sesquihydrate or piperidine), a 5-HT 2 receptor antagonist (Meizel & Turner 1983) .
Mammalian spermatozoa are capacitated before fertilization. Capacitated spermatozoa exhibit the AR in their heads and hyperactivation of the flagella (Yanagimachi 1994 , Fujinoki 2009 ). The AR is a modified exocytotic event involving an acrosome and is required for penetration of the zona pellucida (ZP) of the egg and sperm-egg plasma membrane fusion (Yudine et al. 1988 , Yanagimachi 1994 . Hyperactivation is a specialized movement of the sperm flagellum that creates the propulsive force for penetration of the ZP. Hyperactivated spermatozoa exhibit a high amplitude, asymmetrical beating pattern of the sperm flagellum (Yanagimachi 1994 , Fujinoki et al. 2001a , Suarez & Ho 2003 . Capacitation occurs artificially in a specific culture medium containing albumin, HCO K 3 , and Ca 2C . Albumin is an essential component for capacitation to occur (Fujinoki 2008 , Noguchi et al. 2008 , as it removes cholesterol from the sperm plasma smembrane to change its fluidity (Langlais & Roberts 1985) . HCO K 3 stimulates AC, thereby increasing cAMP levels (Okamura et al. 1985) . cAMP activates protein kinase A (PKA), leading to protein serine/threonine phosphorylation and to sperm flagellar movement , Visconti et al. 1999 , Fujinoki et al. 2003 , 2004a , 2004b , 2006 . In many cases, protein tyrosine phosphorylation also occurs in a cAMP-dependent manner (Visconti et al. 1995 , 1999 , Fujinoki et al. 2001b . Ca 2C is involved in many intracellular signal transductions, including regulation of AC, and phosphodiesterase and protein phosphorylation , Ho & Suarez 2001 , Breitbart 2002 , Ho et al. 2002 , Marín-Briggiler et al. 2005 .
Several studies have demonstrated that the AR is induced by ligands such as progesterone, the ZP, serotonin, and melatonin (Meizel & Turner 1983 , Osman et al. 1989 , Luconi et al. 2004 , Baldi et al. 2009 , Casao et al. 2009 ). However, hyperactivation is also enhanced by ligands such as progesterone and melatonin (Sueldo et al. 1993 , Yang et al. 1994 , Fujinoki 2008 , 2009 , Noguchi et al. 2008 , du Plessis et al. 2010 . Moreover, progesterone-enhanced hyperactivation was suppressed by 17b-estradiol (Fujinoki 2010) . These ligands regulate the AR and hyperactivation via nongenomic regulation. Non-genomic regulation of the AR and hyperactivation by progesterone and the ZP are associated with Ca 2C signals via PLC (Luconi et al. 2004 , Noguchi et al. 2008 , Baldi et al. 2009 , Fujinoki 2009 ). However, non-genomic regulation of the AR and hyperactivation by melatonin are associated with nitric oxide signals (Fujinoki 2008 , 2009 , Casao et al. 2009 , du Plessis et al. 2010 . However, regulation of the AR by serotonin is poorly understood. Moreover, it has yet to be determined whether serotonin enhances hyperactivation, although it is known to induce the AR (Meizel & Turner 1983) . Accordingly, in this study, the effects of serotonin on hyperactivation using hamster spermatozoa were investigated.
Results

Effects of serotonin on hyperactivation
In a previous study (Fujinoki 2008) , hyperactivation was significantly enhanced when melatonin at concentrations between 1 fmol/l and 10 mmol/l was added to the Tyrode's albumin lactate pyruvate (mTALP) medium. As melatonin is a metabolite of serotonin, it was examined whether serotonin enhanced hyperactivation. Serotonin at concentrations between 1 fmol/l and 1 mmol/l significantly enhanced hyperactivation (Fig. 1A) , but serotonin did not affect the percentage of motile spermatozoa when added to the TALP medium at concentrations between 1 amol/l and 10 mmol/l (data not shown). With incubation for 0 h, no hyperactivated spermatozoa were seen (Fig. 1A) . After incubation for 0.5 h, there were a few hyperactivated spermatozoa, but serotonin did not enhance hyperactivation (Fig. 1A) . After incubation for 1 h (Fig. 1B) , 100 nmol/l serotonin significantly enhanced hyperactivation in comparison with mTALP or 1 amol/l serotonin. Hyperactivation was significantly enhanced by 10 nmol/l serotonin in comparison with mTALP or serotonin at 1 or 10 amol/l. Similarly, hyperactivation was significantly enhanced by 10 pmol/l serotonin in comparison with mTALP or serotonin at 1 amol/l, 10 amol/l, 1 mmol/l, or 10 mmol/l. Hyperactivation was significantly enhanced by serotonin at concentrations between 1 fmol/l and 1 pmol/l, as well as 100 pmol/l and 1 nmol/l serotonin, in comparison with mTALP or serotonin at 1 amol/l, 10 amol/l, or 10 mmol/l. Although the increase was not significant, 
e e e e e e e e f f Figure 1 Dose-dependent effects of serotonin on hyperactivation. The percentage of hyperactivated spermatozoa is shown (A) as an overview of effects after incubation for (B) 1, (C) 1.5, and (D) 2 h after serotonin was added to mTALP medium. Data are given as meanGS.D. (mTALP): mTALP; (1 amol/l or K18): mTALPC1 amol/l serotonin; (K17): mTALPC10 amol/l serotonin; (K16): mTALPC100 amol/l serotonin; (1 fmol/l or K15): mTALPC1 fmol/l serotonin; (K14): mTALP C10 fmol/l serotonin; (K13): mTALPC100 fmol/l serotonin; (1 pmol/l or K12): mTALPC1 pmol/l serotonin; (K11): mTALPC10 pmol/l serotonin; (K10): mTALPC100 pmol/l serotonin; (1 nmol/l or K9): mTALPC1 nmol/l serotonin; (K8): mTALPC10 nmol/l serotonin; (K7): mTALPC100 nmol/l serotonin; (1 mmol/l or K6): mTALP C1 mmol/l serotonin; (K5): mTALPC10 mmol/l serotonin. a Significant difference in comparison with mTALP or 1 amol/l serotonin; b significant difference in comparison with mTALP or 1 amol/l or 10 amol/l serotonin; c significant difference in comparison with mTALP or 1 amol/l, 10 amol/l, 1 mmol/l, or 10 mmol/l serotonin; d significant difference in comparison with mTALP or 1 amol/l, 10 amol/l, or 10 mmol/l serotonin; e significant difference in comparison with mTALP or between 1 amol/l and 100 amol/l, 1 mmol/l, and 10 mmol/l serotonin; f significant difference in comparison with mTALP or between 1 amol/l and 100 amol/l or 10 mmol/l serotonin; g significant difference in comparison with 1 amol/l or between 1 fmol/l and 1 mmol/l serotonin.
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serotonin at 100 amol/l enhanced hyperactivation. After incubation for 1.5 h (Fig. 1C) , serotonin at 1 and 10 fmol/l significantly enhanced hyperactivation in comparison with mTALP or serotonin at 1 amol/l. Hyperactivation was significantly enhanced by 10 nmol/l serotonin in comparison with mTALP or serotonin at 1 amol/l, 10 amol/l, or 10 mmol/l. Moreover, serotonin at concentrations between 100 fmol/l and 1 nmol/l significantly enhanced hyperactivation in comparison with mTALP or serotonin at concentrations between 1 amol/l and 100 amol/l, 1 mmol/l, or 10 mmol/l. After incubation for 2 h (Fig. 1D ), serotonin at concentrations between 10 pmol/l and 100 nmol/l significantly enhanced hyperactivation in comparison with mTALP or serotonin at concentrations between 1 amol/l and 100 amol/l, 1 mmol/l, or 10 mmol/l. Serotonin at 1 fmol/l and 1 mmol/l significantly enhanced hyperactivation in comparison with mTALP or serotonin at concentrations between 1 amol/l and 100 amol/l and 10 mmol/l serotonin. Moreover, serotonin at 100 amol/l significantly enhanced hyperactivation compared with serotonin at 1 amol/l or concentrations between 1 fmol/l and 1 mmol/l. After incubation for 2.5, 3, and 4 h, most motile spermatozoa were hyperactivated under all conditions (Fig. 1A) .
Effects of 5-HT receptor agonists on hyperactivation
Quipazine is a nonspecific 5-HT receptor agonist, although Meizel & Turner (1983) reported that it was a 5-HT receptor antagonist and significantly suppressed serotonin-induced AR. Accordingly, it was examined whether quipazine acted as an antagonist to serotoninenhanced hyperactivation using 100 pmol/l serotonin, an average value of the effective concentrations, and 1 mmol/l quipazine (Fig. 2) . Although 1 mmol/l quipazine did not affect the percentage of motile spermatozoa (data not shown), it significantly enhanced hyperactivation ( Fig. 2A) . After incubation for 0 and 0.5 h, no hyperactivated spermatozoa were seen ( Fig. 2A) . After incubation for 1 (Fig. 2B ), 1.5 (Fig. 2C) , and 2 h (Fig. 2D ), serotonin and quipazine significantly enhanced hyperactivation in comparison with mTALP. When spermatozoa were exposed to 100 pmol/l serotonin after exposure to 1 mmol/l quipazine, hyperactivation was significantly enhanced in comparison with mTALP. However, no significant difference was seen between 'serotoninC quipazine' and serotonin or quipazine respectively. After incubation for 2 h (Fig. 2D) , serotonin significantly enhanced hyperactivation compared with quipazine. After incubation for 2.5, 3, and 4 h, most motile spermatozoa were hyperactivated under all conditions ( Fig. 2A) . These results indicate that quipazine acts as agonist for hyperactivation.
In the next step, the dose-dependent effect of quipazine on hyperactivation was examined (Fig. 3) . When quipazine concentrations between 1 amol/l and 10 mmol/l were added to mTALP medium, quipazine did not affect the percentage of motile spermatozoa (data not shown), but at concentrations between 100 amol/l and 1 mmol/l, quipazine affected the percentage of hyperactivated spermatozoa (Fig. 3A) . After incubation for 0 h, no hyperactivated spermatozoa were seen (Fig. 3A) . After incubation for 0.5 h, quipazine did not significantly enhance hyperactivation, with but a few spermatozoa hyperactivated (Fig. 3A) . After incubation for 1 h (Fig. 3B ), quipazine at a concentration of 1 fmol/l and between 1 pmol/l and 10 nmol/l significantly enhanced hyperactivation in comparison with mTALP or quipazine at 1 amol/l, 1 mmol/l, or 10 mmol/l. Quipazine at 10 and 100 fmol/l significantly enhanced hyperactivation in The serotonin-induced AR was reportedly suppressed by quipazine (Meizel & Turner 1983) , although quipazine is a non-specific 5-HT receptor agonist. After spermatozoa were exposed to 1 mmol/l quipazine for 5 min, they were exposed to 100 pmol/l serotonin. The percentage of hyperactivated spermatozoa is shown (A) as an overview of effects after incubation for (B) 1, (C) 1.5, and (D) 2 h when serotonin and quipazine were added to mTALP medium. Data are given as meanGS.D. 'mTALP', 'serotonin', 'quipazine', and 'serotoninCquipazine' indicate mTALP, mTALPC100 pmol/l serotonin, mTALP C1 mmol/l quipazine, and mTALPC100 pmol/l serotoninC1 mmol/l quipazine. comparison with mTALP or quipazine at 1 amol/l, 10 amol/l, 1 mmol/l, or 10 mmol/l. Moreover, 100 amol/ l quipazine significantly enhanced hyperactivation in comparison with mTALP or quipazine at 1 amol/l and 10 mmol/l. After incubation for 1.5 h (Fig. 3C ), quipazine at concentrations between 1 and 100 fmol/l significantly enhanced hyperactivation in comparison with mTALP or quipazine at 1 or 10 mmol/l. Quipazine at 1 and 100 pmol/l significantly enhanced hyperactivation in comparison with mTALP or quipazine at concentrations of 1 amol/l, 10 amol/l, or between 100 nmol/l and 10 mmol/l. Quipazine at 10 pmol/l significantly enhanced hyperactivation in comparison with mTALP or quipazine at 10 amol/l, 1 mmol/l, or 10 mmol/l. Quipazine at 1 nmol/l quipazine significantly enhanced hyperactivation in comparison with mTALP or 10 mmol/l quipazine. Although the increase was not significant, quipazine at 100 amol/l and 10 nmol/l enhanced hyperactivation. After incubation for 2 h (Fig. 3D ), quipazine at 100 amol/l and 1 mmol/l significantly enhanced hyperactivation in comparison with mTALP. Quipazine at concentrations between 1 fmol/l and 100 nmol/l significantly enhanced hyperactivation in comparison with mTALP or quipazine at 1 and 10 amol/ l. After incubation for 2.5, 3, and 4 h, most motile spermatozoa were hyperactivated under all conditions ( Fig. 3A) . Because serotonin-induced AR is regulated via 5-HT 2 and 5-HT 4 receptors (Meizel & Turner 1983) , it was examined whether 5-HT 2 and 5-HT 4 receptor agonists enhanced hyperactivation (Figs 4 and 5). When a-methylserotonin, a 5-HT 2 receptor agonist, was added to the mTALP medium at concentrations between 1 amol/l and 10 mmol/l, it did not affect the percentage of motile spermatozoa (data not shown), although a-methylserotonin at concentrations between 1 fmol/l and 100 pmol/l did affect the percentage of hyperactivated spermatozoa (Fig. 4A) . At incubation for 0 h, there were no hyperactivated spermatozoa (Fig. 4A ). After incubation for 0.5 h (Fig. 4B ), a-methylserotonin at 1 fmol/l significantly enhanced hyperactivation in comparison with mTALP or a-methylserotonin at concentrations of 1 amol/l, 10 amol/l, or between 10 pmol/l and 10 mmol/l. a-Methylserotonin at 10 fmol/l significantly enhanced hyperactivation in comparison with mTALP or a-methylserotonin at concentrations of 1 amol/l, 10 amol/l, or between 1 nmol/l and 10 mmol/l. Moreover, 100 fmol/l a-methylserotonin significantly enhanced hyperactivation in comparison with mTALP or a-methylserotonin at concentrations of 1 amol/l, 10 amol/l, or between 100 pmol/l and 10 mmol/l. After incubation for 1 h (Fig. 4C) , a-methylserotonin at 1 and 10 fmol/l significantly enhanced hyperactivation in comparison with mTALP or a-methylserotonin at concentrations of 1 amol/l, 10 amol/l, or between 100 nmol/l and 10 mmol/l. a-Methylserotonin at 100 fmol/l significantly enhanced hyperactivation in comparison with mTALP or 1 amol/l a-methylserotonin. Although the increase was not significant, a-methylserotonin at concentrations between 1 and 100 nmol/l enhanced hyperactivation. After incubation for 1.5 h 
Figure 3 Significant difference in comparison with mTALP or 1 amol/l, 1 mmol/l, or 10 mmol/l quipazine; (Fig. 4D) , a-methylserotonin at 1 and 10 fmol/l significantly enhanced hyperactivation in comparison with mTALP or a-methylserotonin at concentrations between 1 and 100 amol/l or between 100 pmol/l and 10 mmol/l. a-Methylserotonin at 100 fmol/l significantly enhanced hyperactivation in comparison with mTALP or a-methylserotonin at concentrations between 1 and 100 amol/l or between 1 nmol/l and 10 mmol/l. Moreover, a-methylserotonin at 1 and 10 pmol/l significantly enhanced hyperactivation in comparison with mTALP or a-methylserotonin at concentrations between 1 nmol/l and 10 mmol/l. After incubation for 2 h (Fig. 4E) , a-methylserotonin at concentrations between 1 and 100 fmol/l significantly enhanced hyperactivation in comparison with mTALP or a-methylserotonin at concentrations of 1 amol/l, 10 amol/l, or between 1 nmol/l and 10 mmol/l. a-Methylserotonin at 1 pmol/l significantly enhanced hyperactivation in comparison with mTALP or a-methylserotonin at 1 amol/l, 10 amol/l, 1 mmol/l, or 10 mmol/l. Moreover, a-methylserotonin at 10 and 100 pmol/l significantly enhanced hyperactivation in comparison with 1 mmol/l a-methylserotonin. After incubation for 2.5, 3, and 4 h, most motile spermatozoa were hyperactivated under all conditions (Fig. 4A) .
In the next step, when 5-methoxytryptamine, a 5-HT 4 receptor agonist, was added to the mTALP medium at concentrations between 1 amol/l and 10 mmol/l, it did not affect the percentage of motile spermatozoa (data not shown), whereas 5-methoxytryptamine at concentrations between 1 fmol/l and 100 nmol/l affected the percentage of hyperactivated spermatozoa (Fig. 5A) . After incubation for 0 h, no hyperactivated spermatozoa were seen (Fig. 5A) . After incubation for 0.5 h, 5-methoxytryptamine at concentrations between 1 fmol/l and 100 nmol/l enhanced hyperactivation, although the increase was not significant (Fig. 5A ). After incubation for 1 h (Fig. 5B) , 5-methoxytryptamine at 10 and 100 fmol/l significantly enhanced hyperactivation in comparison with mTALP. Although the increase was not significant, 5-methoxytryptamine at concentrations of 1 fmol/l and between 1 pmol/l and 100 nmol/l enhanced hyperactivation. After incubation for 1.5 h (Fig. 5C ), 5-methoxytryptamine at 1 and 10 fmol/l significantly enhanced hyperactivation in comparison with mTALP or 5-methoxytryptamine at concentrations between 1 amol/l and 100 amol/l or 1 mmol/l or 10 mmol/l. 5-Methoxytryptamine at 100 fmol/l and 1 pmol/l significantly enhanced hyperactivation in comparison with mTALP or 5-methoxytryptamine at concentrations between 1 and 100 amol/l or between 100 nmol/l and 10 mmol/l 5-methoxytryptamine. 5-Methoxytryptamine at concentrations of 10 pmol/l and between 1 and 100 nmol/l significantly enhanced hyperactivation in comparison with mTALP or 5-methoxytryptamine at 1 amol/l, 10 amol/l, 1 mmol/l, or 10 mmol/l. 5-Methoxytryptamine at 100 pmol/l significantly enhanced hyperactivation in comparison with mTALP or 5-methoxytryptamine at concentrations between 1 amol/l and 100 amol/l or 1 mmol/l or 10 mmol/l 5-methoxytryptamine. After incubation for 2 h (Fig. 5D) , 5-methoxytryptamine at concentrations between 1 fmol/l and 100 nmol/l significantly enhanced hyperactivation in comparison with mTALP or 5-methoxytryptamine at 1 amol/l, 10 amol/l, or 10 mmol/l. After incubation for 2.5, 3, and 4 h, most motile spermatozoa were hyperactivated under all conditions (Fig. 5A ).
Effects of 5-HT receptor antagonists on serotoninenhanced hyperactivation
As both the 5-HT 2 receptor agonist (a-methylserotonin) and the 5-HT 4 receptor agonist (5-methoxytryptamine) enhanced sperm hyperactivation, it was examined whether a 5-HT 2 receptor antagonist (cyproheptadine) and 5-HT 4 receptor antagonist (GR113808) suppressed serotonin-enhanced and agonist-enhanced hyperactivation. Cyproheptadine at 1 mmol/l significantly suppressed serotonin-enhanced (Fig. 6A) , quipazine-enhanced (Fig. 6C) , and a-methylserotonin-enhanced hyperactivation (Fig. 7A) , although it did not affect the percentages of motile (data not shown) or hyperactivated spermatozoa (Figs 6 and 7) , or of 5-methoxytryptamine-enhanced hyperactivation (Fig. 7B) . Cyproheptadine significantly suppressed serotonin-enhanced and quipazineenhanced hyperactivation when spermatozoa were exposed to 100 pmol/l serotonin or 100 pmol/l quipazine, the respective average effective concentrations, after exposure to 1 mmol/l cyproheptadine for 5 min ( Fig. 6A and C) . However, cyproheptadine did not suppress serotonin-enhanced and quipazine-enhanced hyperactivation when spermatozoa were exposed to 100 nmol/l serotonin and 100 nmol/l quipazine, the respective maximum effective concentrations, after exposure to 1 mmol/l cyproheptadine for 5 min (Fig. 6B  and D) . When spermatozoa were exposed to 100 fmol/l a-methylserotonin, the average effective concentration, after exposure to 1 mmol/l cyproheptadine for 5 min, cyproheptadine significantly suppressed a-methylserotonin-enhanced hyperactivation (Fig. 7A) . However, 5-methoxytryptamine-enhanced hyperactivation was not suppressed by cyproheptadine when spermatozoa 
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were exposed to 10 pmol/l 5-methoxytryptamine, the average effective concentration, after exposure to 1 mmol/l cyproheptadine for 5 min (Fig. 7B) .
GR113808 at 1 mmol/l also significantly suppressed serotonin-enhanced (Fig. 8A) , quipazine-enhanced (Fig. 8C) , and 5-methoxytryptamine-enhanced hyperactivation (Fig. 9B) , although GR113808 did not affect the percentages of motile (data not shown) or hyperactivated spermatozoa (Figs 8 and 9 ). GR113808 significantly suppressed serotonin-enhanced and quipazineenhanced hyperactivation when spermatozoa were exposed to 100 nmol/l serotonin and 100 nmol/l quipazine after exposure to 1 mmol/l GR113808 for 5 min ( Fig. 8A and C) . When spermatozoa were exposed to 100 pmol/l serotonin and 100 pmol/l quipazine after exposure to 1 mmol/l GR113808 for 5 min, however, GR113808 did not suppress serotonin-enhanced and quipazine-enhanced hyperactivation ( Fig. 8B  and D) . When spermatozoa were exposed to 100 fmol/l a-methylserotonin after exposure to 1 mmol/l GR113808 for 5 min, a-methylserotonin-enhanced hyperactivation was not suppressed by GR113808 (Fig. 9A) . However, 5-methoxytryptamine-enhanced hyperactivation was suppressed by 1 mmol/l GR113808 when spermatozoa were exposed to 10 pmol/l 5-methoxytryptamine after exposure to 1 mmol/l GR113808 for 5 min (Fig. 9B) .
Effects of Ca 2C and albumin on hyperactivation
Progesterone and melatonin significantly enhance hyperactivation, although they are not associated with the spontaneous regulatory mechanisms of hyperactivation (Fujinoki 2008 , Noguchi et al. 2008 . Accordingly, it was examined whether serotonin-enhanced hyperactivation is associated with the spontaneous regulatory mechanisms of hyperactivation. As shown in Fig. 10A , the percentage of motile spermatozoa was significantly decreased after incubation for 1 h in mTALP medium without Ca 2C , and after incubation for 2.5, 3, or 4 h, most spermatozoa were not motile. Serotonin did not affect the percentage of motile spermatozoa in mTALP medium without Ca 2C . Spermatozoa were not hyperactivated in mTALP medium without Ca 2C , even if serotonin was added (Fig. 10B) .
In mTALP medium without BSA, most spermatozoa were not hyperactivated even if serotonin was added (Fig. 10C) . However, the addition of BSA did not affect the percentage of motile spermatozoa (data not shown).
Discussion
Recent studies have been suggested that hyperactivation is regulated in a ligand-dependent manner, with ligands including progesterone, 17b-estradiol, and melatonin (Sueldo et al. 1993 , Yang et al. 1994 Figure 6 Effects of cyproheptadine on serotonin-enhanced and quipazineenhanced hyperactivation. After spermatozoa were exposed to cyproheptadine for 5 min, they were exposed to serotonin or quipazine. The percentages of hyperactivated spermatozoa (A-D) are shown when 100 pmol/l serotonin, 100 nmol/l serotonin, 100 pmol/l quipazine, 100 nmol/l quipazine, and 1 mmol/l cyproheptadine were added to mTALP medium. Data are given as meanGS.D. In (A), 'vehicle', '100 pmol/l serotonin', 'cyproheptadine', and '100 pmol/l serotoninCcyproheptadine' indicate mTALPC0.1% MeOH, mTALPC100 pmol/l serotoninC0.1% MeOH, mTALPC1 mmol/l cyproheptadineC0.1% MeOH and mTALP C100 pmol/l serotoninC1 mmol/l cyproheptadineC0.1% MeOH. In (B), 'vehicle', '100 nmol/l serotonin', 'cyproheptadine', and '100 nmol/l serotoninCcyproheptadine' indicate mTALPC0.1% MeOH, mTALP C100 nmol/l serotoninC0.1% MeOH, mTALPC1 mmol/l cyproheptadineC0.1% MeOH and mTALPC100 nmol/l serotoninC1 mmol/l cyproheptadineC0.1% MeOH. In (C), 'vehicle', '100 pmol/l quipazine', 'cyproheptadine', and '100 pmol/l quipazineCcyproheptadine' indicate mTALPC0.1% MeOH, mTALPC100 pmol/l quipazineC0.1% MeOH, mTALPC1 mmol/l cyproheptadineC0.1% MeOH and mTALPC 100 pmol/l quipazineC1 mmol/l cyproheptadineC0.1% MeOH. In (D), 'vehicle', '100 nmol/l quipazine', 'cyproheptadine', and '100 nmol/l quipazineCcyproheptadine' indicate mTALPC0.1% MeOH, mTALP C100 nmol/l quipazineC0.1% MeOH, mTALPC1 mmol/l cyproheptadineC0.1% MeOH and mTALPC100 nmol/l quipazineC1 mmol/l cyproheptadineC0.1% MeOH. Those ligands are also associated with regulation of the AR (Osman et al. 1989 , Luconi et al. 2004 , Baldi et al. 2009 , Casao et al. 2009 .
In this study, it was examined whether serotonin and its agonists are associated with regulation of hyperactivation, because a previous study (Meizel & Turner 1983) demonstrated that serotonin and its agonists induce the AR in hamster spermatozoa. Serotonin and quipazine significantly enhanced hyperactivation in a dose-dependent manner (see Figs 1-3) . For hamster spermatozoa, the effective concentration ranges of serotonin and quipazine were 1 fmol/l to 1 mmol/l and 100 amol/l to 1 mmol/l respectively. As the effective concentration range of melatonin for enhancement of hyperactivation is 1 pmol/l to 1 mmol/l (Fujinoki 2008) , serotonin is more potent than melatonin. In general, the actions of serotonin are mediated by 5-HT receptors (Noda et al. 2004 , Ganong 2005 . A previous study (Meizel & Turner 1983) demonstrated that serotonin and 5-methoxytryptamine induce the AR and that both serotonin-induced and 5-methoxytryptamine-induced AR are inhibited by cyproheptadine. Therefore, it is likely that serotonin induces the AR via 5-HT 2 and 5-HT 4 receptors. Both a-methylserotonin and 5-methoxytryptamine significantly enhanced sperm hyperactivation in a dose-dependent manner (see Figs  4 and 5) . The effective concentration ranges of a-methylserotonin and 5-methoxytryptamine were 1 fmol/l to 100 pmol/l and 1 fmol/l to 100 nmol/l respectively. Moreover, cyproheptadine and GR113808 suppressed a-methylserotonin-enhanced and 5-methoxytryptamine-enhanced hyperactivation respectively (see Figs 7 and 9) . Interestingly, enhancement of hyperactivation by 100 pmol/l serotonin and 100 pmol/l quipazine were significantly suppressed by cyproheptadine (see Fig. 6A and C) , although enhancement of hyperactivation by 100 nmol/l serotonin and 100 nmol/l quipazine were not suppressed by cyproheptadine (see Fig. 6B and D) . However, enhancement of hyperactivation by 100 nmol/l serotonin and 100 nmol/l quipazine were significantly suppressed by GR113808 (see Fig. 8A and C), whereas enhancement of hyperactivation by 100 pmol/l serotonin and 100 pmol/l quipazine were not suppressed by GR113808 (see Fig. 8B and D) . These results suggest that serotonin enhances hyperactivation via the 5-HT 2 and 5-HT 4 receptors in a dose-dependent manner.
Generally, 5-HT 2 receptor and 5-HT 4 receptors are activated by PLC and AC respectively (Noda et al. 2004 , Ganong 2005 . Activation of PLC induces production of inositol 1,4,5-tris-phosphate (IP 3 ) and diacylglycerol, increases intracellular Ca 2C , and activates protein kinase C. In mammalian spermatozoa, PLC is associated with the regulation of progesteroneinduced AR and progesterone-enhanced hyperactivation (Luconi et al. 2004 , Noguchi et al. 2008 , Baldi et al. 2009 , Fujinoki 2009 ). It has been suggested that IP 3 is also associated with regulation of hyperactivation (Ho & Suarez 2001) . Because serotonin-enhanced hyperactivation was regulated via 5-HT 2 receptors (see Figs 4, 6 and 7), it is likely that 100 pmol/l serotonin and a-methylserotonin enhance hyperactivation through 5-HT 2 receptors and PLC-IP 3 signals. In progesterone-enhanced hyperactivation, tyrosine phosphorylation of sperm proteins is enhanced and increased after activation of PLC (Noguchi et al. 2008 , Fujinoki 2009 , 2010 . Although it is not clear whether serotonin enhances and increases tyrosine phosphorylation of sperm proteins together with enhancement of hyperactivation, it is my understanding that tyrosine phosphorylation is enhanced and increased when serotonin enhances hyperactivation. However, serotonin also enhanced hyperactivation via 5-HT 4 receptors (see Figs 5, 8 and 9 ). As 5-HT 4 receptor induces activation of AC and cAMP production, it is likely that 100 nmol/l serotonin and 5-methoxytryptamine enhance hyperactivation through Figure 7 Effects of cyproheptadine on a-methylserotonin-enhanced and 5-methoxytryptamine-enhanced hyperactivation. After spermatozoa were exposed to cyproheptadine for 5 min, they were exposed to a-methylserotonin or 5-methoxytryptamine. The percentages of hyperactivated spermatozoa (A and B) are shown when 100 fmol/l a-methylserotonin, 10 pmol/l 5-methoxytryptamine, and 1 mmol/l cyproheptadine were added to mTALP medium. Data are given as meanGS.D. In (A), 'vehicle', 'a-methylserotonin', 'cyproheptadine', and 'a-methylserotoninCcyproheptadine' indicate mTALPC0.1% MeOH, mTALPC100 fmol/l a-methylserotonin, C0.1% MeOH, mTALPC1 mmol/l cyproheptadineC0.1% MeOH and mTALP C100 fmol/l a-methylserotonin, C1 mmol/l cyproheptadineC0.1% MeOH. In (B), 'vehicle', '5-methoxytryptamine', 'cyproheptadine', and '5-methoxytryptamineCcyproheptadine' indicate mTALPC0.1% MeOHC0.1% EtOH, mTALPC10 pmol/l 5-methoxytryptamine C0.1% MeOHC0.1% EtOH, mTALPC1 mmol/l cyproheptadineC0.1% MeOHC0.1% EtOH and mTALPC10 pmol/l 5-methoxytryptamine C1 mmol/l cyproheptadineC0.1% MeOHC0.1% EtOH. 5-HT 4 receptors and AC-cAMP signals. In general, hyperactivation is regulated by cAMP-PKA signals (Yanagimachi 1994 , Visconti et al. 1995 . In addition, tyrosine phosphorylation is also regulated by cAMP/ PKA signals (Visconti et al. 1995 , 1999 , Fujinoki et al. 2006 . Therefore, it is reasonable to assume that serotonin also enhances and increases tyrosine phosphorylation together with hyperactivation through 5-HT 4 receptors and AC-cAMP-PKA signals.
Progesterone-enhanced and melatonin-enhanced hyperactivation are not associated with the spontaneous regulatory mechanisms, because these enhancements only occur in complete media in which spermatozoa can be hyperactivated (Fujinoki 2008 , Noguchi et al. 2008 . Serotonin-enhanced hyperactivation also occurred in the complete medium in which spermatozoa could be hyperactivated and did not occur in media without Ca 2C or albumin (see Fig. 10 ). Therefore, it is likely that serotonin-enhanced hyperactivation also occurs through a modulatory mechanism, as with progesteroneenhanced and melatonin-enhanced hyperactivation.
Serotonin and 5-HT receptors are found in oocytes, COC, follicular fluid, and embryos in mammals (Dubé & Amireault 2007) . The serotonin content in the rat oviduct ranged from 2.06 to 3.34 mg/g fresh tissue (Juorio et al. 1989) . In human, serotonin in the preovulatory follicles and the cystically degenerated follicles were 14.3G8.9 and 12.2G6.2 mg/100 ml respectively (Bó dis et al. 1992) . In the female reproductive organs, serotonin is mainly released from cumulus cells and is associated with the regulation of steroidogenesis and oocyte maturation (Dubé & Amireault 2007) . Serotonin at 100 pmol/l induced progesterone released from human granulose cells (Bódis et al. 1993) . The results of a previous study (Meizel & Turner 1983) and this study both suggest that serotonin directly induces the AR and enhances hyperactivation. The effective concentrations of serotonin to induce the AR and to enhance hyperactivation are several mmol/l and between 1 fmol/l and 1 mmol/l respectively (Meizel & Turner 1983, see Fig. 1 ). The AR occurs near or at oocytes and the COC. In contrast, hyperactivation occurs at a distance from oocytes and the COC. Therefore, it is likely that serotonin regulates sperm functions depending on the distance between the spermatozoa and the oocytes. Spermatozoa have various systems to regulate sperm functions depending on the distance between spermatozoa and oocytes. Progesterone enhances hyperactivation (Noguchi et al. 2008 , Fujinoki 2009 ). However, 17b-estradiol suppresses enhancement of hyperactivation by progesterone (Fujinoki 2010) . Melatonin also enhances hyperactivation (Fujinoki 2008) . Those hormones are contained in follicular fluid and are found in reproductive fluids. Therefore, it seems that spermatozoa have several regulatory systems to regulate the timing of fertilization using hormones released from oocytes, COC, or follicular fluid. Figure 8 Effects of GR113808 on serotonin-enhanced and quipazineenhanced hyperactivation. After spermatozoa were exposed to GR113808 for 5 min, they were exposed to serotonin or quipazine. The percentages of hyperactivated spermatozoa (A-D) are shown when 100 nmol/l serotonin, 100 pmol/l serotonin, 100 nmol/l quipazine, 100 pmol/l quipazine, and 1 mmol/l GR113808 were added to mTALP medium. Data are given as meanGS.D. In (A), 'vehicle', '100 nmol/l serotonin', 'GR113808', and '100 nmol/l serotoninCGR113808' indicate mTALPC0.1% DMSO, mTALPC100 nmol/l serotoninC0.1% DMSO, mTALPC1 mmol/l GR113808C0.1% DMSO, and mTALP C100 nmol/l serotoninC1 mmol/l GR113808C0.1% DMSO. In (B), 'vehicle', '100 pmol/l serotonin', 'GR113808', and '100 pmol/l serotoninCGR113808' indicate mTALPC0.1% DMSO, mTALP C100 pmol/l serotoninC0.1% DMSO, mTALPC1 mmol/l GR113808C0.1% DMSO, and mTALPC100 pmol/l serotonin C1 mmol/l GR113808C0.1% DMSO. In (C), 'vehicle', '100 nmol/l quipazine', 'GR113808', and '100 nmol/l quipazineCGR113808' indicate mTALPC0.1% DMSO, mTALPC100 nmol/l quipazineC0.1% DMSO, mTALPC1 mmol/l GR113808C0.1% DMSO, and mTALP C100 nmol/l quipazineC1 mmol/l GR113808C0.1% DMSO. In (D), 'vehicle', '100 pmol/l quipazine', 'GR113808', and '100 pmol/l quipazineCGR113808' indicate mTALPC0.1% DMSO, mTALP C100 pmol/l quipazineC0.1% DMSO, mTALPC1 mmol/l GR113808 C0.1% DMSO, and mTALPC100 pmol/l quipazineC1 mmol/l GR113808C0.1% DMSO. cose, 0.09 mmol/l sodium pyruvate, 9 mmol/l sodium lactate, 0.5 mmol/l hypotaurine, 0.05 mmol/l (K)epinephrine, 0.2 mmol/l sodium taurocholic acid, 5.26 mmol/l sodium metabisulfite, 0.05% (w/v) streptomycin sulfate, 0.05% (w/v) potassium penicillin G, and 15 mg/ml BSA (pH 7.4 at 37 8C under 5% (v/v) CO 2 in air). An aliquot of caudal epididymal spermatozoa was placed on a culture plate (35 mm dish) and several milliliters of the medium were carefully added before incubation for 5 min to allow spermatozoa to swim up. The supernatant containing motile spermatozoa was collected, placed on the culture plate, and incubated for 4 h at 37 8C under 5% CO 2 in air to accomplish hyperactivation. Serotonin and agonists were added to the medium after placing motile spermatozoa on the culture plate. For examination of the effects Figure 9 Effects of GR113808 on a-methylserotonin-enhanced and 5-methoxytryptamine-enhanced hyperactivation. After spermatozoa were exposed to GR113808 for 5 min, they were exposed to a-methylserotonin or 5-methoxytryptamine. The percentages of hyperactivated spermatozoa (A and B) are shown when 100 fmol/l a-methylserotonin, 10 pmol/l 5-methoxytryptamine, and 1 mmol/l GR113808 were added to mTALP medium. Data are given as mean GS.D. In (A), 'vehicle', 'a-methylserotonin', 'GR113808', and 'a-methylserotoninCGR113808' indicate mTALPC0.1% DMSO, mTALPC100 fmol/l a-methylserotonin, C0.1% DMSO, mTALP C1 mmol/l GR113808C0.1% DMSO, and mTALPC100 fmol/l a-methylserotonin, C1 mmol/l GR113808C0.1% DMSO. In (B), 'vehicle', '5-methoxytryptamine', 'GR113808', and '5-methoxytryptamineCGR113808' indicate mTALPC0.1% DMSOC0.1% EtOH, mTALPC10 pmol/l 5-methoxytryptamineC0.1% DMSOC0.1% EtOH, mTALPC1 mmol/l GR113808C0.1% DMSOC0.1% EtOH, and mTALPC10 pmol/l 5-methoxytryptamineC1 mmol/l GR113808 C0.1% DMSOC0.1% EtOH. a Significant difference in comparison with 'vehicle' or 'GR113808'. b Significant difference in comparison with 'vehicle' or 'GR113808' or '5-methoxytryptamineCGR113808'. of serotonin antagonists, spermatozoa were exposed to serotonin and agonists after exposure to antagonists for 5 min. Cyproheptadine, 5-methoxytryptamine, and GR113808 were dissolved in methanol (MeOH), ethanol (EtOH), and DMSO. In all experiments, the maximal concentration of vehicle was 0.2%.
Measurement of spermatozoa motility and hyperactivation
Motility and hyperactivation measurements were performed according to the method described by Fujinoki et al. (2006) with some modifications. Spermatozoa suspended in the mTALP medium were diluted tenfold and placed on a culture plate. Motility and hyperactivation were recorded on VHS via a CCD camera (Progressive 3CCD, Sony Corp., Tokyo, Japan) attached to a microscope (IX70, Olympus Corp., Tokyo, Japan) with phase-contrast illumination and a small CO 2 incubator (MI-IBC, Olympus). Each observation was performed at 37 8C, recorded for 2 min, and analyzed by manually counting the number of total spermatozoa, motile spermatozoa, and hyperactivated spermatozoa in ten different fields. Motile spermatozoa that exhibited asymmetric and whiplash flagellar movement and a circular and/or octagonal swimming locus were defined as hyperactivated spermatozoa (Fujinoki et al. 2001a) . Motile spermatozoa (%) and hyperactivated spermatozoa (%) were, respectively, defined as the number of motile spermatozoa/number of total spermatozoa!100, and the number of hyperactivated spermatozoa/number of total spermatozoa!100. Experiments were performed four times using four hamsters. Statistical analyses were performed using the post hoc ANOVA test. P!0.05 was considered significant.
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